217 related articles for article (PubMed ID: 25593319)
1. Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance.
Williams AS; Kang L; Zheng J; Grueter C; Bracy DP; James FD; Pozzi A; Wasserman DH
J Biol Chem; 2015 Mar; 290(10):6546-57. PubMed ID: 25593319
[TBL] [Abstract][Full Text] [Related]
2. Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice.
Kang L; Ayala JE; Lee-Young RS; Zhang Z; James FD; Neufer PD; Pozzi A; Zutter MM; Wasserman DH
Diabetes; 2011 Feb; 60(2):416-26. PubMed ID: 21270253
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
4. Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet.
Camer D; Yu Y; Szabo A; Dinh CH; Wang H; Cheng L; Huang XF
Mol Cell Endocrinol; 2015 Sep; 412():36-43. PubMed ID: 26001833
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte integrin-linked kinase plays a key role in the development of diet-induced adipose insulin resistance in male mice.
Bugler-Lamb AR; Hasib A; Weng X; Hennayake CK; Lin C; McCrimmon RJ; Stimson RH; Ashford MLJ; Wasserman DH; Kang L
Mol Metab; 2021 Jul; 49():101197. PubMed ID: 33647469
[TBL] [Abstract][Full Text] [Related]
6. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
7. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance.
Ayala JE; Bracy DP; James FD; Burmeister MA; Wasserman DH; Drucker DJ
Endocrinology; 2010 Oct; 151(10):4678-87. PubMed ID: 20685876
[TBL] [Abstract][Full Text] [Related]
9. [Deletion of CD36 gene ameliorates glucose metabolism abnormality induced by high-fat diet and promotes liver lipid accumulation].
Luo XQ; Zeng H; Tan W; Yang P; Chen YX; Ruan XZ
Sheng Li Xue Bao; 2021 Oct; 73(5):805-812. PubMed ID: 34708237
[TBL] [Abstract][Full Text] [Related]
10. Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome.
Alwahsh SM; Dwyer BJ; Forbes S; Thiel DH; Lewis PJ; Ramadori G
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134848
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice.
Merry TL; Tran M; Dodd GT; Mangiafico SP; Wiede F; Kaur S; McLean CL; Andrikopoulos S; Tiganis T
Diabetologia; 2016 Dec; 59(12):2632-2644. PubMed ID: 27628106
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-induced hepatic inflammation does not underlie the predisposition to insulin resistance in dyslipidemic female LDL receptor knockout mice.
Gruben N; Funke A; Kloosterhuis NJ; Schreurs M; Sheedfar F; Havinga R; Houten SM; Shiri-Sverdlov R; van de Sluis B; Kuivenhoven JA; Koonen DP; Hofker MH
J Diabetes Res; 2015; 2015():956854. PubMed ID: 25815343
[TBL] [Abstract][Full Text] [Related]
13. Protection from non-alcoholic steatohepatitis and liver tumourigenesis in high fat-fed insulin receptor substrate-1-knockout mice despite insulin resistance.
Nakamura A; Tajima K; Zolzaya K; Sato K; Inoue R; Yoneda M; Fujita K; Nozaki Y; Kubota KC; Haga H; Kubota N; Nagashima Y; Nakajima A; Maeda S; Kadowaki T; Terauchi Y
Diabetologia; 2012 Dec; 55(12):3382-91. PubMed ID: 22955994
[TBL] [Abstract][Full Text] [Related]
14. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor.
Lin HY; Yu IC; Wang RS; Chen YT; Liu NC; Altuwaijri S; Hsu CL; Ma WL; Jokinen J; Sparks JD; Yeh S; Chang C
Hepatology; 2008 Jun; 47(6):1924-35. PubMed ID: 18449947
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.
Joo E; Harada N; Yamane S; Fukushima T; Taura D; Iwasaki K; Sankoda A; Shibue K; Harada T; Suzuki K; Hamasaki A; Inagaki N
Diabetes; 2017 Apr; 66(4):868-879. PubMed ID: 28096257
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.
Fraulob JC; Souza-Mello V; Aguila MB; Mandarim-de-Lacerda CA
Clin Sci (Lond); 2012 Aug; 123(4):259-70. PubMed ID: 22420611
[TBL] [Abstract][Full Text] [Related]
17. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
19. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
[TBL] [Abstract][Full Text] [Related]
20. StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis.
Kakiyama G; Minoiwa K; Bai-Kamara N; Hashiguchi T; Pandak WM; Rodriguez-Agudo D
Am J Physiol Gastrointest Liver Physiol; 2024 Jun; 326(6):G747-G761. PubMed ID: 38591148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
